Fig. 2: Positive symptom dimension by SZ-PRS and cannabis use in FEP patients. | Translational Psychiatry

Fig. 2: Positive symptom dimension by SZ-PRS and cannabis use in FEP patients.

From: The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study

Fig. 2

The graph on the left illustrates the independent and joint effect of daily cannabis use (blue line: no; red line: yes) and SZ-PRS (x axys) on the positive symptom dimension (y axys). The two graphs on the right present the main effect of SZ-PRS (in blue, x axys) and daily cannabis use (in red, x axys) on the positive symptom dimension (y axys). Values are adjusted for age, sex, and 10 ancestry PCs.

Back to article page